Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01)

The summary for the Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01): The purpose of this FOA is to renew the clinical research sites (CRSs) of the Multicenter AIDS Cohort Study (MACS) and continue support for clinical, epidemiologic and basic research on a cohort of men who report sex with men (MSM). The MACS will continue to characterize the long-term, natural and treated history of HIV infection in MSM, provide insight into the clinical epidemiology of HIV, and further our understanding of predictors of disease among HIV positive MSM. The MACS CRSs will also transition to a rolling cohort design to replace existing cohort members who die or otherwise are permanently lost to follow-up. Due to the demonstrated capacity to recruit and retain this unique population, the depth of data and specimens collected over decades, and the need for continued follow-up, this competition will be limited to the current four clinical awardee institutions for the MACS CRSs.

Federal Grant Title:	Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-13-011
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.242
CFDA Descriptions:	Mental Health Research Grants
Current Application Deadline:	Jul 11, 2013
Original Application Deadline:	Jul 11, 2013
Posted Date:	Mar 08, 2013
Creation Date:	Mar 08, 2013
Archive Date:	Aug 11, 2013
Total Program Funding:	$17,900,000
Maximum Federal Grant Award:	$4,200,000
Minimum Federal Grant Award:
Expected Number of Awards:	4
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: 1. Eligible Applicants Eligible Organizations Only applications from the current MACS clinical research sites (CRSs) may be submitted in response to this limited competition: U01-AI035039, Northwestern University (Chicago, IL) Chicago MACS U01-AI035040, University of California at Los Angeles (Los Angeles, CA) Natural History of HIV/AIDS in Homosexual Men: Los Angeles MACS U01-AI035041, University of Pittsburgh (Pittsburgh, PA) The Pittsburgh Men's Study: Pittsburgh MACS U01-AI035042, Johns Hopkins University (Baltimore, MD) The Study to Help the AIDS Research Effort (SHARE): Baltimore MACS Foreign Institutions Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See announcement for more detailed information.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH...; • Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional...; • Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...; • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...; • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional); • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...; • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...; • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...